tirzepatide kidney How the weight loss drug is also helping heart failure patients tirzepatide and kidneys GLP therapies

Focus on obesity treatment for lasting lifestyle change Obesity in adults: Pharmacologic options for successful management Caring for adult patients with obesity in primary care The benefits of GLP-1 RAs extend beyond glycemic control

You draw 50 units out of habit

We are also here to support you if you decide you want to stop treatment

In the SURMOUNT-1 clinical trial, patients taking the highest dose (15 mg) of tirzepatide lost about 21% of their body weight over 72 weeks

How to Properly Use Tirzepatide Administered as a weekly subcutaneous injection, tirzepatide requires consistent use, ideally on the same day each week